Prime Medicine (PRME) Assets Average (2022 - 2026)

Prime Medicine's Assets Average history runs 5 years deep, the most recent figure standing at $318.7 million for Q1 2026.

• Quarterly Assets Average rose 1.88% year-over-year to $318.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $318.7 million (up 1.88% YoY) and the FY2025 annual result came in at $320.1 million, up 30.3% from the prior year.
• Assets Average was $318.7 million for Q1 2026 at Prime Medicine, down from $363.9 million in the prior quarter.
• Across five years, Assets Average topped out at $363.9 million in Q4 2025 and bottomed at $216.5 million in Q4 2023.
• A 5-year average of $298.7 million and a median of $301.2 million in 2023 frame the typical range for Assets Average.
• Peak annual rise in Assets Average reached 45.57% in 2024, while the deepest fall reached 25.4% in 2024.
• Prime Medicine's Assets Average stood at $287.8 million in 2022, then declined by 24.77% to $216.5 million in 2023, then surged by 45.57% to $315.1 million in 2024, then rose by 15.46% to $363.9 million in 2025, then slipped by 12.41% to $318.7 million in 2026.
• Business Quant data shows PRME's Assets Average at $318.7 million in Q1 2026, $363.9 million in Q4 2025, and $332.0 million in Q3 2025.